Lexicon Pharmaceuticals
LXRX
LXRX
122 hedge funds and large institutions have $697M invested in Lexicon Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 44 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less funds holding in top 10
Funds holding in top 10: →
36% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 44
39% less capital invested
Capital invested by funds: $1.15B → $697M (-$450M)
74% less call options, than puts
Call options by funds: $640K | Put options by funds: $2.44M
Holders
122
Holding in Top 10
2
Calls
$640K
Puts
$2.44M
Top Buyers
| 1 | +$2.14M | |
| 2 | +$1.68M | |
| 3 | +$1.53M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.15M |
| 5 |
Citigroup
New York
|
+$861K |
Top Sellers
| 1 | -$5.72M | |
| 2 | -$5.64M | |
| 3 | -$5.08M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.54M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.76M |